In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer

Genomics. 2009 Jan;93(1):52-61. doi: 10.1016/j.ygeno.2008.08.002. Epub 2008 Oct 22.

Abstract

Gastric cancer is one of the most common cancers worldwide, and there are clinical caveats in predicting tumor response to chemotherapy. This study describes the construction of an in vitro pharmacogenomic database, and the selection of genes associated with chemosensitivity in gastric cancer cell lines. Gene expression and chemosensitivity databases were integrated using the Pearson correlation coefficient to give the GC-matrix. The 85 genes were selected that were commonly associated with chemosensitivity of the major anticancer drugs. We then focused on the genes that were highly correlated with each specific drug. Classification of cell lines based on the set of genes associated with each drug was consistent with the division into resistant or sensitive groups according to the chemosensitivity results. The GC-matrix of the gastric cancer cell line database was used to identify different sets of chemosensitivity-related genes for specific drugs or multiple drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Databases, Genetic
  • Drug Resistance, Neoplasm
  • Gene Expression Profiling*
  • Humans
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism*
  • Oligonucleotide Array Sequence Analysis
  • Predictive Value of Tests
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / genetics*

Substances

  • Antineoplastic Agents
  • Neoplasm Proteins